Press Releases
November 9, 2023
Panbela Provides Business Update and Reports Q3 2023 Financial Results
November 3, 2023
Panbela Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9M Gross Proceeds Priced At-the-Market
November 2, 2023
Panbela Announces Publication of Preclinical and Clinical Data: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes
A Phase 1 clinical study showed that DFMO treatment may provide metabolic benefits to preserve β cell function and health in T1D.
October 31, 2023
Panbela Announces Validation of European Patent for Claims of a Novel Process for the Production of SBP-101
October 25, 2023
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication
October 24, 2023
Panbela to Host Third Quarter 2023 Earnings Conference Call on 11/9/23
September 26, 2023
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101
September 19, 2023
Panbela to Present at the LD Micro Investor Conference
September 5, 2023
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
August 28, 2023
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
Events & Presentations